News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
180,426 Results
Type
Article (13146)
Company Profile (23)
Press Release (167257)
Multimedia
Podcasts (10)
Webinars (5)
Section
Business (49826)
Career Advice (611)
Deals (9300)
Drug Delivery (30)
Drug Development (28928)
Employer Resources (69)
FDA (4793)
Job Trends (3921)
News (93400)
Policy (8043)
Tag
Academia (1081)
Academic (1)
Accelerated approval (1)
Adcomms (6)
Allergies (37)
Alliances (13918)
ALS (38)
Alzheimer's disease (438)
Antibody-drug conjugate (ADC) (24)
Approvals (4801)
Artificial intelligence (66)
Autoimmune disease (8)
Automation (3)
Bankruptcy (72)
Best Places to Work (3269)
BIOSECURE Act (6)
Biosimilars (35)
Biotechnology (11)
Bladder cancer (25)
Brain cancer (8)
Breast cancer (85)
Cancer (617)
Cardiovascular disease (70)
Career advice (514)
Career pathing (13)
CAR-T (46)
Cell therapy (110)
Cervical cancer (9)
Clinical research (24664)
Collaboration (184)
Compensation (22)
Complete response letters (2)
COVID-19 (1090)
CRISPR (10)
C-suite (59)
Cystic fibrosis (20)
Data (827)
Denatured (7)
Depression (10)
Diabetes (113)
Diagnostics (1761)
Digital health (3)
Diversity (5)
Diversity, equity & inclusion (28)
Drug discovery (40)
Drug pricing (42)
Drug shortages (16)
Duchenne muscular dystrophy (33)
Earnings (15121)
Editorial (18)
Employer branding (5)
Employer resources (63)
Events (21987)
Executive appointments (190)
FDA (5161)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (209)
Gene editing (20)
Generative AI (7)
Gene therapy (87)
GLP-1 (284)
Government (1200)
Grass and pollen (2)
Guidances (34)
Healthcare (5486)
Huntington's disease (6)
IgA nephropathy (9)
Immunology and inflammation (34)
Indications (7)
Infectious disease (1136)
Inflammatory bowel disease (57)
Inflation Reduction Act (4)
Influenza (16)
Intellectual property (18)
Interviews (104)
IPO (3593)
IRA (19)
Job creations (777)
Job search strategy (450)
Kidney cancer (2)
Labor market (7)
Layoffs (84)
Leadership (9)
Legal (1542)
Liver cancer (21)
Lung cancer (68)
Lymphoma (42)
Machine learning (2)
Management (22)
Manufacturing (70)
MASH (37)
Medical device (3237)
Medtech (3239)
Mergers & acquisitions (5864)
Metabolic disorders (241)
Multiple sclerosis (42)
NASH (16)
Neurodegenerative disease (22)
Neuropsychiatric disorders (4)
Neuroscience (627)
NextGen: Class of 2025 (2040)
Non-profit (1693)
Obesity (107)
Opinion (49)
Ovarian cancer (17)
Pain (35)
Pancreatic cancer (22)
Parkinson's disease (56)
Partnered (7)
Patents (32)
Patient recruitment (39)
Peanut (17)
People (17577)
Pharmaceutical (11)
Pharmacy benefit managers (9)
Phase I (5523)
Phase II (10630)
Phase III (9995)
Pipeline (363)
Policy (57)
Postmarket research (1168)
Preclinical (2024)
Press Release (29)
Prostate cancer (38)
Psychedelics (9)
Radiopharmaceuticals (65)
Rare diseases (112)
Real estate (1386)
Recruiting (23)
Regulatory (5971)
Reports (13)
Research institute (904)
Resumes & cover letters (82)
Rett syndrome (1)
RSV (18)
Schizophrenia (24)
Series A (48)
Series B (33)
Service/supplier (2)
Sickle cell disease (15)
Special edition (2)
Spinal muscular atrophy (66)
Sponsored (6)
Startups (1189)
Stomach cancer (4)
Supply chain (15)
Tariffs (9)
The Weekly (3)
Vaccines (285)
Venture capitalists (8)
Weight loss (74)
Women's health (15)
Worklife (7)
Date
Last 7 days (230)
Last 30 days (663)
Last 365 days (8214)
2025 (2902)
2024 (8832)
2023 (10060)
2022 (13366)
2021 (15075)
2020 (14632)
2019 (13837)
2018 (10645)
2017 (9726)
2016 (9315)
2015 (11037)
2014 (7529)
2013 (5848)
2012 (6341)
2011 (6734)
2010 (5806)
Location
Africa (252)
Alabama (7)
Alaska (4)
Arizona (42)
Arkansas (2)
Asia (12700)
Australia (2430)
California (1407)
Canada (407)
China (156)
Colorado (56)
Connecticut (51)
Delaware (43)
Europe (33700)
Florida (179)
Georgia (79)
Idaho (14)
Illinois (150)
India (11)
Indiana (93)
Iowa (2)
Japan (73)
Kansas (31)
Kentucky (8)
Louisiana (6)
Maine (13)
Maryland (226)
Massachusetts (922)
Michigan (41)
Minnesota (86)
Missouri (21)
Montana (6)
Nebraska (6)
Nevada (20)
New Hampshire (10)
New Jersey (462)
New Mexico (7)
New York (497)
North Carolina (197)
Northern California (635)
Ohio (41)
Oklahoma (3)
Oregon (4)
Pennsylvania (339)
Puerto Rico (3)
Rhode Island (4)
South America (375)
South Carolina (8)
Southern California (555)
Tennessee (18)
Texas (172)
United States (5343)
Utah (23)
Virginia (27)
Washington D.C. (7)
Washington State (162)
Wisconsin (11)
180,426 Results for "ck group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
Cytokinetics, Incorporated announced topline data from the Phase 1 study of CK-4021586.
May 8, 2024
·
7 min read
Press Releases
Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089
November 11, 2024
·
5 min read
Press Releases
Cytokinetics Announces Start of AMBER-HFpEF, a Phase 2 Clinical Trial of CK-586 in Patients With Symptomatic Heart Failure With Preserved Ejection Fraction
January 21, 2025
·
9 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Press Releases
Cellenkos Presents Phase 1b Data at ASH 2024 Showcasing the Potential of T-Regulatory Cell Therapy Candidate CK0804 for Myelofibrosis
December 10, 2024
·
4 min read
Press Releases
Cytokinetics Announces Data From Phase 1 Study of CK-4021586
September 9, 2024
·
8 min read
Press Releases
Cytoki Pharma Announces First Patient Dosed in Phase 2 Study of CK-0045 in Obesity and Type 2 Diabetes
November 4, 2024
·
4 min read
Press Releases
Orion Group Interim Report January–March 2025
April 23, 2025
·
6 min read
Press Releases
World Ovarian Cancer Coalition Launches Global Expert Advisory Group on Ovarian Cancer
May 8, 2025
·
4 min read
Press Releases
Sunflower Therapeutics Announces an Exclusive Sales Representation Agreement with Optimal Biotech Group
April 30, 2025
·
3 min read
1 of 18,043
Next
